Adding cetuximab to concurrent chemoradiotherapy did not improve overall survival in patients with adenocarcinoma or squamous cell carcinoma of the esophagus.
Jennifer Powers, PhD
Articles by Jennifer Powers, PhD
Latest Updated Articles
Addition of Cetuximab to Chemoradiation in Esophageal Cancer Does Not Improve OSPublished: July 3rd 2014 | Updated: